Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-6606
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Knee osteoarthritis accelerates amyloid beta deposition and neurodegeneration in a mouse model of Alzheimer’s disease ; volume:16 ; number:1 ; day:2 ; month:1 ; year:2023 ; pages:1-10 ; date:12.2023
Molecular brain ; 16, Heft 1 (2.1.2023), 1-10, 12.2023
- Urheber
-
Gupta, Deepak Prasad
Lee, Young-Sun
Choe, Youngshik
Kim, Kun-Tae
Song, Gyun Jee
Hwang, Sun-Chul
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13041-022-00986-9
- URN
-
urn:nbn:de:101:1-2023031209202158006689
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gupta, Deepak Prasad
- Lee, Young-Sun
- Choe, Youngshik
- Kim, Kun-Tae
- Song, Gyun Jee
- Hwang, Sun-Chul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease